Gene · 3945
Papers2,881
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,881
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Maternal LDHB Safeguards Redox Balance and Developmental Competence During Preimplantation Embryo Cleavage. | FASEB J | 2026 | 42117986 | PubTator, text mining | PubMed |
| Identification of small-molecule autophagy activators via GFP-LC3 high-throughput screening and a cargo-based autophagy flux and processing assay. | Eur J Pharmacol | 2026 | 42114732 | PubTator, text mining | PubMed |
| Vitexin inhibits renal cell carcinoma progression by targeting Galectin-1-mediated glycolytic metabolism. | Mol Biol Rep | 2026 | 42113369 | PubTator, text mining | PubMed |
| Proteomic and Metabolomic Profiling Reveal Mitochondrial Transplantation-Mediated Reprogramming in Gastric Cancer Cells. | Kaohsiung J Med Sci | 2026 | 42099017 | PubTator, text mining | PubMed |
| The inhibitory effect of hepatic cancer energy metabolism on immune checkpoint therapy: perspectives from single-cell multi-omics analysis. | Front Immunol | 2026 | 42051493 | PubTator, text mining | PubMed |
| Helicobacter pylori activates histone lactylation to promote gastric cancer progression and immune evasion through the HAS2/c-MYC/PD-L1 axis. | Gut Microbes | 2026 | 42021123 | PubTator, text mining | PubMed |
| UCHL1 promotes osteosarcoma progression via deubiquitination and stabilization of LDHB. | Discov Oncol | 2026 | 41998400 | PubTator, text mining | PubMed |
| Dysregulated lactate metabolism synergizes with ALS genetic risk factors to accelerate motor decline. | PLoS One | 2026 | 41996350 | PubTator, text mining | PubMed |
| Stem cell function in vivo is supported by an alternative glycolysis endpoint. | bioRxiv | 2026 | 41959348 | PubTator, text mining | PubMed |
| Multiomics integration of single-cell transcriptomics and bulk sequencing data identifies key biomarkers and predictive models for IBD subtype classification. | Front Med (Lausanne) | 2026 | 41939783 | PubTator, text mining | PubMed |
| Inflammatory arthritis irAE may represent a unique autoimmune disease primarily driven by T cells but likely not autoantibodies. | Sci Adv | 2026 | 41920990 | PubTator, text mining | PubMed |
| Spatial multi-omics characterization of neuroblastoma reveals ferroptosis-associated metabolic features in high-risk tumors. | Genome Med | 2026 | 41918107 | PubTator, text mining | PubMed |
| [Research Progress on Glycolytic Reprogramming and Lactylation Crosstalk in Tumors]. | Zhongguo Fei Ai Za Zhi | 2026 | 41916915 | PubTator, text mining | PubMed |
| Cell-Type-Dependent Metabolic Compensation Preserves Photoreceptor Survival Through Pyruvate Kinase Isoform Balance. | FASEB J | 2026 | 41915386 | PubTator, text mining | PubMed |
| Mechanism of ribosome stalling by the AMD1 C-terminal tail arrest peptide. | Sci Adv | 2026 | 41894501 | PubTator, text mining | PubMed |
| Current Insights into Clinical, Molecular, and Therapeutic Approaches to Acute Respiratory Distress Syndrome. | Med Sci (Basel) | 2026 | 41892849 | PubTator, text mining | PubMed |
| Unveiling lactylation: A novel frontier in the pathogenesis of diabetic nephropathy (Review). | Int J Mol Med | 2026 | 41891971 | PubTator, text mining | PubMed |
| LDHA protects vascular endothelial cells from oxidative stress‑induced mitochondrial damage via HIF‑1α activation and glycolytic reprogramming. | Mol Med Rep | 2026 | 41891951 | PubTator, text mining | PubMed |
| H3K18 lactylation promotes POM121 transcription and accelerates gastric cancer progression via the PI3K/AKT pathway. | Pathol Res Pract | 2026 | 41864048 | PubTator, text mining | PubMed |
| LDH isozymes as targets for cancer therapy. | J Enzyme Inhib Med Chem | 2026 | 41837490 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3945/papers?page=2